1. Home
  2. NTRA vs BCE Comparison

NTRA vs BCE Comparison

Compare NTRA & BCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo BCE Inc.

BCE

BCE Inc.

HOLD

Current Price

$23.56

Market Cap

21.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
BCE
Founded
2003
1880
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
21.5B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
BCE
Price
$244.06
$23.56
Analyst Decision
Strong Buy
Hold
Analyst Count
16
3
Target Price
$227.69
$29.50
AVG Volume (30 Days)
1.7M
2.9M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
5.36%
EPS Growth
N/A
7324.86
EPS
N/A
4.80
Revenue
$2,116,676,000.00
$17,579,277,614.00
Revenue This Year
$32.77
$1.89
Revenue Next Year
$16.51
$3.03
P/E Ratio
N/A
$4.95
Revenue Growth
38.17
0.11
52 Week Low
$125.38
$20.28
52 Week High
$245.59
$27.28

Technical Indicators

Market Signals
Indicator
NTRA
BCE
Relative Strength Index (RSI) 80.03 56.45
Support Level $233.67 $23.10
Resistance Level $240.18 $23.77
Average True Range (ATR) 7.39 0.39
MACD 0.68 0.07
Stochastic Oscillator 97.49 86.45

Price Performance

Historical Comparison
NTRA
BCE

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About BCE BCE Inc.

BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to HBO Max and Starz.

Share on Social Networks: